April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Evaluation Of Intra-choroidal Implant For Sustained Intraocular Delivery Of Betamethasone Phosphate
Author Affiliations & Notes
  • Masatoshi Murata
    Murata Eye Clinic, Morioka, Japan
  • Saburo Horiuchi
    Iwate Medical University, Morioka, Japan
  • Sanai Sato
    Ideta Eye Hospital, Kumamoto, Japan
  • Saori Murata
    Murata Eye Clinic, Morioka, Japan
  • Footnotes
    Commercial Relationships  Masatoshi Murata, None; Saburo Horiuchi, None; Sanai Sato, None; Saori Murata, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 472. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Masatoshi Murata, Saburo Horiuchi, Sanai Sato, Saori Murata; Evaluation Of Intra-choroidal Implant For Sustained Intraocular Delivery Of Betamethasone Phosphate. Invest. Ophthalmol. Vis. Sci. 2011;52(14):472.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To investigate the feasibility of intra-choroidal implant, we examined the release of betamethasone phosphate (BP) from the intra-choroidal implant in rabbit eye.

Methods: : The intra-choroidal implant was made of poly(DL-lactide) containing 50% BP( 0.15mg ). Under an operating microscope, a sclerotomy was made 6mm posterior to limbus. Choroid was exposed, and an incision was made. A spatula was then inserted into the intra-choroid through this opening and a cylindrical pocket was created. The implant prepared as above was inserted into a choroidal pocket in the rabbit’s eye. To determine how long the effect of implantation lasts, the concentration of BP in the choroid was measured by high-performance liquid chromatography (HPLC).

Results: : Slit lamp examination showed no significant inflammatory reaction at the implantation sites at 4 weeks. Ophthalmoscopically, treated eyes were shown a whitish lesion, corresponding to the site of the BP-loaded implant. The BP concentration in choroid at 4 weeks after implantation was 7.4 ± 6.9 µg/ml ( n = 4, mean ± SD ). This confirmed that the level of BP in the choroid was effectively maintained for at least 4 weeks after intra-choroidal implantation.

Conclusions: : The result suggests that this new intra-choroidal implantation technique can be used as a sustained intra-ocular drug delivery system.

Keywords: drug toxicity/drug effects • choroid 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.